Ranbaxy Labs plans products basket expansion in Russian market

摘要

Ranbaxy Laboratories Ltd. which has completed two decades of operations in Russia, is mulling expansion of its product portfolio to induct value-added and innovator products from parent company, Daiichi Sankyo. "The company established its operations in the Russian market in 1993 with the launch of 'Cifran'. Since then, Ranbaxy has grown to become a No. 1 player with a market share of 15.4% in the represented market segment in Russia," the company said in a press note.